Almazov National Medical Research Centre
Russia
1 June 2019 - 31 May 2020
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Almazov National Medical Research Centre published between 1 June 2019 - 31 May 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
| Count | Share |
|---|---|
| 1 | 0 |
Outputs by subject (Share)
| Subject | Count | Share | |
|---|---|---|---|
| Life Sciences | 1 | 0 | |
Top articles by Altmetric score in current window
AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders
Nature Communications
2019-07-12
1 June 2019 - 31 May 2020
International vs. domestic collaboration by Share
- 0.31% Domestic
- 99.69% International
Note: Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators by Share (1 total)
- Almazov National Medical Research Centre, Russia
- Domestic institution
Top 10 international collaborators by Share (149 total)
- Almazov National Medical Research Centre, Russia
- Foreign institution
-
University College London (UCL), United Kingdom (UK)
(0.13)
-
Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Italy
(0.10)
-
GeneDx Inc., United States of America (USA)
(0.03)
-
University of Washington (UW), United States of America (USA)
(0.03)
-
University of Messina (UNIME), Italy
(0.03)
-
University of Genova, Italy
(0.02)
-
Assistance Publique-Hôpitaux de Paris (AP-HP), France
(0.02)
-
Central South University (CSU), China
(0.02)
-
University of Lagos (Unilag), Nigeria
(0.02)
-
Leiden University, Netherlands
(0.02)
Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
